194 related articles for article (PubMed ID: 34836176)
41. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.
Andrikopoulos P; Kieswich J; Pacheco S; Nadarajah L; Harwood SM; O'Riordan CE; Thiemermann C; Yaqoob MM
J Am Soc Nephrol; 2019 Jan; 30(1):33-49. PubMed ID: 30530834
[TBL] [Abstract][Full Text] [Related]
42. No difference in renal injury and fibrosis between wild-type and NOD1/NOD2 double knockout mice with chronic kidney disease induced by ureteral obstruction.
Stroo I; Emal D; Butter LM; Teske GJ; Claessen N; Dessing MC; Girardin SE; Florquin S; Leemans JC
BMC Nephrol; 2018 Apr; 19(1):78. PubMed ID: 29609537
[TBL] [Abstract][Full Text] [Related]
43. Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.
Marchal PO; Kavvadas P; Abed A; Kazazian C; Authier F; Koseki H; Hiraoka S; Boffa JJ; Martinerie C; Chadjichristos CE
PLoS One; 2015; 10(9):e0137876. PubMed ID: 26367310
[TBL] [Abstract][Full Text] [Related]
44. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy.
Omori H; Kawada N; Inoue K; Ueda Y; Yamamoto R; Matsui I; Kaimori J; Takabatake Y; Moriyama T; Isaka Y; Rakugi H
Clin Exp Nephrol; 2012 Aug; 16(4):549-56. PubMed ID: 22350467
[TBL] [Abstract][Full Text] [Related]
45. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.
Lok SWY; Yiu WH; Li H; Xue R; Zou Y; Li B; Chan KW; Chan LYY; Leung JCK; Lai KN; Tang SCW
Clin Sci (Lond); 2020 Nov; 134(21):2873-2891. PubMed ID: 33078834
[TBL] [Abstract][Full Text] [Related]
46. Testicular Toxicity of Water Pipe Smoke Exposure in Mice and the Effect of Treatment with Nootkatone Thereon.
Ali BH; Al-Salam S; Adham SA; Al Balushi K; Al Za'abi M; Beegam S; Yuvaraju P; Manoj P; Nemmar A
Oxid Med Cell Longev; 2019; 2019():2416935. PubMed ID: 31341528
[TBL] [Abstract][Full Text] [Related]
47. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
[TBL] [Abstract][Full Text] [Related]
48. Ameliorating effect of Klotho on endoplasmic reticulum stress and renal fibrosis induced by unilateral ureteral obstruction.
Liu QF; Ye JM; Deng ZY; Yu LX; Sun Q; Li SS
Iran J Kidney Dis; 2015 Jul; 9(4):291-7. PubMed ID: 26174456
[TBL] [Abstract][Full Text] [Related]
49. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
50. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
[TBL] [Abstract][Full Text] [Related]
51. Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation.
Zheng M; Cai J; Liu Z; Shu S; Wang Y; Tang C; Dong Z
J Cell Mol Med; 2019 Jun; 23(6):3995-4004. PubMed ID: 30993884
[TBL] [Abstract][Full Text] [Related]
52. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
[TBL] [Abstract][Full Text] [Related]
53. STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression.
Makitani K; Ogo N; Asai A
Physiol Rep; 2020 Oct; 8(20):e14627. PubMed ID: 33112058
[TBL] [Abstract][Full Text] [Related]
54. Nootkatone, a neuroprotective agent from Alpiniae Oxyphyllae Fructus, improves cognitive impairment in lipopolysaccharide-induced mouse model of Alzheimer's disease.
Wang Y; Wang M; Xu M; Li T; Fan K; Yan T; Xiao F; Bi K; Jia Y
Int Immunopharmacol; 2018 Sep; 62():77-85. PubMed ID: 29990697
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
Kim J; Imig JD; Yang J; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F971-80. PubMed ID: 25164080
[TBL] [Abstract][Full Text] [Related]
56. Ameliorating effect of troxerutin in unilateral ureteral obstruction induced renal oxidative stress, inflammation, and apoptosis in male rats.
Kaeidi A; Taghipour Z; Allahtavakoli M; Fatemi I; Hakimizadeh E; Hassanshahi J
Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):879-888. PubMed ID: 31900517
[TBL] [Abstract][Full Text] [Related]
57. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
Wang W; Ma BL; Xu CG; Zhou XJ
Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
[TBL] [Abstract][Full Text] [Related]
58. In Vivo Protective Effects of Nootkatone against Particles-Induced Lung Injury Caused by Diesel Exhaust Is Mediated via the NF-κB Pathway.
Nemmar A; Al-Salam S; Beegam S; Yuvaraju P; Hamadi N; Ali BH
Nutrients; 2018 Feb; 10(3):. PubMed ID: 29495362
[TBL] [Abstract][Full Text] [Related]
59. Nigella sativa extract is a potent therapeutic agent for renal inflammation, apoptosis, and oxidative stress in a rat model of unilateral ureteral obstruction.
Hosseinian S; Ebrahimzadeh Bideskan A; Shafei MN; Sadeghnia HR; Soukhtanloo M; Shahraki S; Samadi Noshahr Z; Khajavi Rad A
Phytother Res; 2018 Nov; 32(11):2290-2298. PubMed ID: 30070029
[TBL] [Abstract][Full Text] [Related]
60. Suppression of TRPM2 reduces renal fibrosis and inflammation through blocking TGF-β1-regulated JNK activation.
Wang Y; Chen L; Wang K; Da Y; Zhou M; Yan H; Zheng D; Zhong S; Cai S; Zhu H; Li Y
Biomed Pharmacother; 2019 Dec; 120():109556. PubMed ID: 31655312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
